Login to Your Account


Beigene's PD-1 antibody gets clinical study approval in China

By Shannon Ellis
Staff Writer

Monday, September 12, 2016

SHANGHAI – China's regulatory authorities have given Beigene Co. Ltd., the green light to study BGB-A317, a fully human PD-1 antibody, on patients in China.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription


»

For Sales Inquiries,
http://clarivate.com/life-sciences/news/bioworld/#

 
Privacy Policy | Terms of Use | Copyright
 
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Clarivate Analytics